News for CNS Pharmaceuticals, Inc. (CNSP)

Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:

U.S. stocks traded mixed midway through trading, with the S&P 500 and Nasdaq Composite edging higher on Wednesday. The Dow traded down 0.39% to 44,382.16 while...

U.S. stocks traded lower this morning, with the Dow Jones index falling around 150 points on Wednesday. The Dow traded down 0.33% to 44,408.16 while the NASDAQ...

HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing i

General Motors ends robotaxi development. Bausch & Lomb falls amid report Blackstone may drop out of takeover bid. Microsoft shareholders vote no on bitcoin despite Michael Saylor's pitch.

HOUSTON, TX / ACCESSWIRE / November 18, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the

CNS Pharmaceuticals reports Q3 2024 financial results, showing a net loss of $5.6 million and cash reserves of $7.0 million as of September 30th.

Court upholds FDA approval of Avadel's narcolepsy drug LUMRYZ

Shares of Tesla, Inc. TSLA rose sharply in today's pre-market trading after the company reported stronger-than-expected earnings for its third quarter. The aut...

CNS Pharmaceuticals secures $3 million in registered direct offering

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling more than 1% on Wednesday. The Dow traded down 1.32% to 42,358.19 while the NASDAQ...

U.S. stocks traded lower this morning, with the Dow Jones index dipping more than 250 points on Wednesday. Following the market opening Wednesday, the Dow trad...

Texas-based CNS Pharmaceuticals, Inc., (CNSP), a clinical pharmaceutical company, is up over 143 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Texas-based CNS Pharmaceuticals, Inc., (CNSP), a clinical pharmaceutical company, is up over 143 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Shares of Stride, Inc. LRN rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and issued...

Shares of Palantir Technologies Inc PLTR rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter results. Pal...

Shares of Merck & Co., Inc. MRK fell sharply during Tuesday's session after the company reported second-quarter financial results and cut its FY24 adjusted EPS ...

London-based VivoPower International PLC (VVPR) is up over 121 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Loading... Loading... Shares of Ovid Therapeutics Inc OVID dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endpoin...